Products Categories
  • Ms.Lisa
    Tel: 86-0512-62805756

  • Mobile:18013112728
  • Tel:86-0512-62805756
  • Fax:86-0512-62805756
  • Province/state:jiangsu
  • City:Suzhou
  • Street:Dushuhu Building,No 1031 Tongda Road,Wuzhong District ,Suzhou China
  • MaxCard:
Home > Products >  Weight loss raw material Nutritional supplement orlistat

Weight loss raw material Nutritional supplement orlistat CAS NO.96829-58-2

  • Min.Order: 1 Kilogram
  • Payment Terms: T/T,
  • Product Details

Keywords

  • orlistat
  • orlistat powder

Quick Details

  • ProName: Weight loss raw material Nutritional s...
  • CasNo: 96829-58-2
  • Molecular Formula: C29H53NO5
  • Appearance: White crystalline power
  • Application: CAS:96829-58-2
  • DeliveryTime: 3-5 working days after payment
  • PackAge: 25kg/drum or according customers' requ...
  • Port: shanghai
  • ProductionCapacity: 1 Metric Ton/Month
  • Purity: 99%
  • Storage: cool and dry place
  • Transportation: DHL fedex EMS TNT
  • LimitNum: 1 Kilogram

Superiority

1.Active workteam and strict company system

2.Chinese factory's price and high purity,product is fresh

3.Rich experience of exporting pharmaceutical drug raw material

4.A large number of reliable containers loading in Chinese sea port

5.Fast shipment and friendly service after marketing

6.Good reputation and friendly cooperation in Europe and Southeast Asia

Details

Name
Orlistat
Appearance White fine powder     
Cas   96829-58-2
MF     C6H10N2O3
MW 495.73
Boiling point     615.9°C
Assay                                 99%
Grade Medicine grade
Package 25kg/drum
Usage         Weight lose               
 
Orlistat is used for the treatment of obesity.The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body mass.After orlistat was stopped, a significant number of subjects regained weight_up to 35% of the weight they had lost.
The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).
 
If You Have Any Questions, Please Let Me Konw, We Are Always At Your Service !
Tel:0086-18013112728
Skype:catherinehoujinhg
Fax:0086-0512-62805756
E-mail:catherine@cnhoujin.com

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog